MX2021016053A - Formulaciones de espuma rectal. - Google Patents

Formulaciones de espuma rectal.

Info

Publication number
MX2021016053A
MX2021016053A MX2021016053A MX2021016053A MX2021016053A MX 2021016053 A MX2021016053 A MX 2021016053A MX 2021016053 A MX2021016053 A MX 2021016053A MX 2021016053 A MX2021016053 A MX 2021016053A MX 2021016053 A MX2021016053 A MX 2021016053A
Authority
MX
Mexico
Prior art keywords
foam formulations
rectal foam
rectal
methods
formulations
Prior art date
Application number
MX2021016053A
Other languages
English (en)
Inventor
Crilles Casper Larsen
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2021016053A publication Critical patent/MX2021016053A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En el presente documento se describen formulaciones farmacéuticas de espuma rectal que son útiles, por ejemplo, para la administración rectal de agentes terapéuticos tales como el ácido 5-aminosalicílico (5-ASA), así como los métodos para elaborar tales formulaciones de espuma y los métodos terapéuticos que las utilizan.
MX2021016053A 2016-12-16 2019-06-12 Formulaciones de espuma rectal. MX2021016053A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662435265P 2016-12-16 2016-12-16

Publications (1)

Publication Number Publication Date
MX2021016053A true MX2021016053A (es) 2022-02-03

Family

ID=60937825

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019006924A MX2019006924A (es) 2016-12-16 2017-12-14 Formulaciones de espuma rectal.
MX2021016053A MX2021016053A (es) 2016-12-16 2019-06-12 Formulaciones de espuma rectal.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019006924A MX2019006924A (es) 2016-12-16 2017-12-14 Formulaciones de espuma rectal.

Country Status (12)

Country Link
US (1) US20190351060A1 (es)
EP (1) EP3554473A1 (es)
JP (2) JP2020503296A (es)
KR (1) KR20190110092A (es)
CN (1) CN110430869A (es)
AU (1) AU2017377017A1 (es)
BR (1) BR112019012122A2 (es)
CA (1) CA3046938A1 (es)
IL (1) IL267347A (es)
MX (2) MX2019006924A (es)
RU (1) RU2757275C2 (es)
WO (1) WO2018109717A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4326233A1 (en) * 2021-04-22 2024-02-28 TDL Innovations, LLC Foam compositions for treating clostridioides difficile infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
SE9000485D0 (sv) * 1990-02-09 1990-02-09 Pharmacia Ab Foamable composition for pharmaceutical use, use thereof and method of treatment
IT1243379B (it) * 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
FR2713486B1 (fr) * 1993-12-14 1996-02-09 Scophysa Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues.
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
EP2422768B1 (en) * 2003-08-25 2015-04-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
WO2007054818A2 (en) * 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
WO2009150530A2 (en) * 2008-06-11 2009-12-17 Ferring International Center Sa Novel foam composition
EP2140866A1 (en) * 2008-07-04 2010-01-06 Bayer Schering Pharma Aktiengesellschaft Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
MX2012005883A (es) * 2009-11-23 2012-10-09 Cipla Ltd Composicion topica en espuma.

Also Published As

Publication number Publication date
AU2017377017A1 (en) 2019-07-04
IL267347A (en) 2019-08-29
RU2757275C2 (ru) 2021-10-12
BR112019012122A2 (pt) 2019-11-05
EP3554473A1 (en) 2019-10-23
US20190351060A1 (en) 2019-11-21
MX2019006924A (es) 2019-10-09
JP2020503296A (ja) 2020-01-30
KR20190110092A (ko) 2019-09-27
RU2019119495A (ru) 2021-01-18
CN110430869A (zh) 2019-11-08
RU2019119495A3 (es) 2021-03-24
JP2022163191A (ja) 2022-10-25
WO2018109717A1 (en) 2018-06-21
CA3046938A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
PH12016502552A1 (en) Formulation comprising a gemcitabine-prodrug
MX2018008190A (es) Sistemas y metodos para la administracion transdermica a largo plazo.
MX2019015744A (es) Composiciones farmaceuticas.
CL2018000622A1 (es) Acetamida tienodiazepinas de triazol y sus usos relacionados.
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
PH12018501072A1 (en) Modified release orally administered amino acid formulations
CO2020005485A2 (es) Administración oral de análogos del péptido glp-1
MX2021004439A (es) Formulacion solida oral que contiene irinotecan y metodo de preparacion de la misma.
MX2022006817A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2018005872A (es) Profarmacos de acido nucleico.
MX2019011613A (es) Formulaciones de acido 1-amino-1-ciclopropanocarboxilico.
BR112018071363A2 (pt) composições farmacêuticas orais de nicotinamida
MY178960A (en) Hiv treatment formulation of atazanavir and cobicistat
MX2020013389A (es) Composiciones de terlipresina y usos de las mismas.
GEP20237486B (en) Formulations of copanlisib
MX2021016053A (es) Formulaciones de espuma rectal.
MX2019010640A (es) Formas cristalinas de acido obeticolico.
MX2017008931A (es) Formulaciones farmaceuticas de xantina o derivados de xantina.
CY1123966T1 (el) Διαδικασια για την παρασκευη νατριουχου εποπροστενολης ενισχυμενης σταθεροτητας